237 related articles for article (PubMed ID: 8246904)
1. Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: studies of bicyclic cannabinoid analogs.
Melvin LS; Milne GM; Johnson MR; Subramaniam B; Wilken GH; Howlett AC
Mol Pharmacol; 1993 Nov; 44(5):1008-15. PubMed ID: 8246904
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships defining the ACD-tricyclic cannabinoids: cannabinoid receptor binding and analgesic activity.
Melvin LS; Milne GM; Johnson MR; Wilken GH; Howlett AC
Drug Des Discov; 1995 Nov; 13(2):155-66. PubMed ID: 8872458
[TBL] [Abstract][Full Text] [Related]
3. Nonclassical cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model.
Howlett AC; Johnson MR; Melvin LS; Milne GM
Mol Pharmacol; 1988 Mar; 33(3):297-302. PubMed ID: 3352594
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.
Compton DR; Rice KC; De Costa BR; Razdan RK; Melvin LS; Johnson MR; Martin BR
J Pharmacol Exp Ther; 1993 Apr; 265(1):218-26. PubMed ID: 8474008
[TBL] [Abstract][Full Text] [Related]
5. Modeling the cannabinoid receptor: a three-dimensional quantitative structure-activity analysis.
Thomas BF; Compton DR; Martin BR; Semus SF
Mol Pharmacol; 1991 Nov; 40(5):656-65. PubMed ID: 1944237
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a cannabinoid receptor in sea urchin sperm and its role in blockade of the acrosome reaction.
Chang MC; Berkery D; Schuel R; Laychock SG; Zimmerman AM; Zimmerman S; Schuel H
Mol Reprod Dev; 1993 Dec; 36(4):507-16. PubMed ID: 8305215
[TBL] [Abstract][Full Text] [Related]
7. Development of a novel class of monocyclic and bicyclic alkyl amides that exhibit CB1 and CB2 cannabinoid receptor affinity and receptor activation.
Berglund BA; Fleming PR; Rice KC; Shim JY; Welsh WJ; Howlett AC
Drug Des Discov; 2000; 16(4):281-94. PubMed ID: 10807034
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.
Schatz AR; Lee M; Condie RB; Pulaski JT; Kaminski NE
Toxicol Appl Pharmacol; 1997 Feb; 142(2):278-87. PubMed ID: 9070350
[TBL] [Abstract][Full Text] [Related]
9. Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids.
Lynn AB; Herkenham M
J Pharmacol Exp Ther; 1994 Mar; 268(3):1612-23. PubMed ID: 8138973
[TBL] [Abstract][Full Text] [Related]
10. Determination and characterization of a cannabinoid receptor in rat brain.
Devane WA; Dysarz FA; Johnson MR; Melvin LS; Howlett AC
Mol Pharmacol; 1988 Nov; 34(5):605-13. PubMed ID: 2848184
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships of indole- and pyrrole-derived cannabinoids.
Wiley JL; Compton DR; Dai D; Lainton JA; Phillips M; Huffman JW; Martin BR
J Pharmacol Exp Ther; 1998 Jun; 285(3):995-1004. PubMed ID: 9618400
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.
Showalter VM; Compton DR; Martin BR; Abood ME
J Pharmacol Exp Ther; 1996 Sep; 278(3):989-99. PubMed ID: 8819477
[TBL] [Abstract][Full Text] [Related]
13. Characterization and autoradiographic localization of the cannabinoid binding site in rat brain using [3H]11-OH-delta 9-THC-DMH.
Thomas BF; Wei X; Martin BR
J Pharmacol Exp Ther; 1992 Dec; 263(3):1383-90. PubMed ID: 1335065
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid.
Pinto JC; PotiƩ F; Rice KC; Boring D; Johnson MR; Evans DM; Wilken GH; Cantrell CH; Howlett AC
Mol Pharmacol; 1994 Sep; 46(3):516-22. PubMed ID: 7935333
[TBL] [Abstract][Full Text] [Related]
15. (Aminoalkyl)indole isothiocyanates as potential electrophilic affinity ligands for the brain cannabinoid receptor.
Yamada K; Rice KC; Flippen-Anderson JL; Eissenstat MA; Ward SJ; Johnson MR; Howlett AC
J Med Chem; 1996 May; 39(10):1967-74. PubMed ID: 8642555
[TBL] [Abstract][Full Text] [Related]
16. Pharmacophoric requirements for cannabinoid side chains: multiple bond and C1'-substituted delta 8-tetrahydrocannabinols.
Papahatjis DP; Kourouli T; Abadji V; Goutopoulos A; Makriyannis A
J Med Chem; 1998 Mar; 41(7):1195-200. PubMed ID: 9544219
[TBL] [Abstract][Full Text] [Related]
17. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study.
Oviedo A; Glowa J; Herkenham M
Brain Res; 1993 Jul; 616(1-2):293-302. PubMed ID: 8395305
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors.
Lake KD; Compton DR; Varga K; Martin BR; Kunos G
J Pharmacol Exp Ther; 1997 Jun; 281(3):1030-7. PubMed ID: 9190833
[TBL] [Abstract][Full Text] [Related]
19. Characterization of two cloned human CB1 cannabinoid receptor isoforms.
Rinaldi-Carmona M; Calandra B; Shire D; Bouaboula M; Oustric D; Barth F; Casellas P; Ferrara P; Le Fur G
J Pharmacol Exp Ther; 1996 Aug; 278(2):871-8. PubMed ID: 8768742
[TBL] [Abstract][Full Text] [Related]
20. Manipulation of the tetrahydrocannabinol side chain delineates agonists, partial agonists, and antagonists.
Martin BR; Jefferson R; Winckler R; Wiley JL; Huffman JW; Crocker PJ; Saha B; Razdan RK
J Pharmacol Exp Ther; 1999 Sep; 290(3):1065-79. PubMed ID: 10454479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]